Lucid Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
LUCD Key Statistics
Stock Snapshot
With a market cap of 183.14M, Lucid Diagnostics(LUCD) trades at $0.90. The stock has a price-to-earnings ratio of -2.00.
As of 2026-09-08, Lucid Diagnostics(LUCD) stock has fluctuated between $0.89 and $0.95. The current price stands at $0.90, placing the stock +1.1% above today's low and -4.9% off the high.
Lucid Diagnostics(LUCD) shares are trading with a volume of 565.26K, against a daily average of 734.56K.
In the last year, Lucid Diagnostics(LUCD) shares hit a 52-week high of $1.63 and a 52-week low of $0.86.
In the last year, Lucid Diagnostics(LUCD) shares hit a 52-week high of $1.63 and a 52-week low of $0.86.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.